Agenta Biotechnologies' Grant

Agenta Biotechnologies raised a round of funding on July 05, 2009. Investors include Qualifying Therapeutic Discovery Project.

Agenta's technologies capitalize on variations of the important biomolecules called proteoglycans, a class of molecules that can promote healing through a variety of known mechanisms. As therapeutics…

Articles about Agenta Biotechnologies' Grant: